万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生1>>眼科学

JOURNAL OF GLAUCOMA《青光眼杂志》 (官网投稿)

简介
  • 期刊简称J GLAUCOMA
  • 参考译名《青光眼杂志》
  • 核心类别 SCI期刊(2019), SCIE期刊(2019), 目次收录(超星), 目次收录(知网),外文期刊,
  • IF影响因子1.992
  • 自引率17.70%
  • 主要研究方向医学-OPHTHALMOLOGY 眼科学

主要研究方向:

等待设置主要研究方向
医学-OPHTHALMOLOGY 眼科学

JOURNAL OF GLAUCOMA《青光眼杂志》(月刊). ​Journal of Glaucoma provides a stimulating forum for discussion of clinical, scientific, and socioeconomic&...[显示全部]
征稿信息

万维提示:

1、投稿方式:官网投稿。

2、期刊网址:

http://journals.lww.com/glaucomajournal/pages/default.aspx

3、投稿网址:

http://www.editorialmanager.com/jog/default.aspx

4、官网邮箱:glaucomajournal@outlook.com(主编)

5、期刊刊期:月刊,一年出版12期。

          20220104日星期二

                   


投稿须知【官网信息】

 

JOURNAL OF GLAUCOMA

AUTHOR INSTRUCTIONS

Ethical/Legal Considerations. A submitted manuscript must be an original contribution not previously published (except as an abstract or preliminary report), must not be under consideration for publication elsewhere, and if accepted, it must not be published elsewhere in similar form, in any language, without the consent of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts, the final responsibility rests with the authors, not with the Journal, its editors, or the publisher. All manuscripts must be submitted online through the journal's electronic submission site www.editorialmanager.com/jog See submission instructions under "Online manuscript submission."

FINANCIAL DISCLOSURE: Each author warrants that he or she has no commercial associations (e.g., consultancies, stock ownership, equity interest, patent/licensing arrangements, etc.) that might pose a conflict of interest in connection with the submitted article, except as disclosed on a separate attachment. All funding sources supporting the Work and all institutional or corporate affiliations of the authors are acknowledged in a footnote in the Work and on the Copyright/Financial Disclosure form that is requested upon acceptance.

Language and Editing Services

It is important that papers are submitted using proper grammar and syntax. Non-native English-speaking authors may consider the aid of editing services. Should you choose to employ professional editing services, please be sure the company you choose has knowledge of ophthalmology terminology and its proper usage.

Wolters Kluwer, in partnership with Editage, offers a unique range of editorial services to help you prepare a submission-ready manuscript:

Premium Editing: Intensive language and structural editing of academic papers to increase chances of journal acceptance.

Advanced Editing: A complete language, grammar, and terminology check to give you a publication-ready manuscript.

Translation with Editing: Write your paper in your native language and Wolters Kluwer Author Services will translate it into English, as well as edit it to ensure that it meets international publication standards.

Plagiarism Check: Helps ensure that your manuscript contains no instances of unintentional plagiarism.

Artwork Preparation: Save precious time and effort by ensuring that your artwork is viewed favorably by the journal without you having to incur the additional cost of purchasing special graphics software.

For more information (including pricing), please visit Wolters Kluwer Author Services

Patient Anonymity and Informed Consent

It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s) with which all the authors are affiliated. Authors should mask patients' eyes and remove patients' names from figures unless they obtain written consent from the patients and submit written consent with the manuscript.

Open access

Authors of accepted peer-reviewed articles have the choice to pay a fee to allow perpetual unrestricted online access to their published article to readers globally, immediately upon publication. Authors may take advantage of the open access option at the point of acceptance to ensure that this choice has no influence on the peer review and acceptance process. These articles are subject to the journal's standard peer-review process and will be accepted or rejected based on their own merit.

The article processing charge (APC) is charged on acceptance of the article and should be paid within 30 days by the author, funding agency or institution. Payment must be processed for the article to be published open access. For a list of journals and pricing please visit our Wolters Kluwer Open Health Journals page.

Authors retain copyright

Authors retain their copyright for all articles they opt to publish open access. Authors grant Wolters Kluwer an exclusive license to publish the article and the article is made available under the terms of a Creative Commons user license. Please visit our Open Access Publication Process page for more information.

Creative Commons license

Open access articles are freely available to read, download and share from the time of publication under the terms of the Creative Commons License Attribution-NonCommerical No Derivative (CC BY-NC-ND) license. This license does not permit reuse for any commercial purposes nor does it cover the reuse or modification of individual elements of the work (such as figures, tables, etc.) in the creation of derivative works without specific permission.

Compliance with funder mandated open access policies

An author whose work is funded by an organization that mandates the use of the Creative Commons Attribution (CC BY) license is able to meet that requirement through the available open access license for approved funders. Information about the approved funders can be found here: http://www.wkopenhealth.com/inst-fund.php

……                                  

更多详情:

https://edmgr.ovid.com/jog/accounts/ifauth.htm


投稿问答最小化  关闭